Banque Cantonale Vaudoise Acquires 8,093 Shares of Danaher Corporation $DHR

Banque Cantonale Vaudoise grew its stake in Danaher Corporation (NYSE:DHR) by 30.1% during the first quarter, HoldingsChannel.com reports. The firm owned 34,989 shares of the conglomerate’s stock after buying an additional 8,093 shares during the period. Banque Cantonale Vaudoise’s holdings in Danaher were worth $6,635,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Apella Capital LLC grew its stake in shares of Danaher by 28.6% during the first quarter. Apella Capital LLC now owns 2,996 shares of the conglomerate’s stock worth $583,000 after purchasing an additional 667 shares during the period. Assenagon Asset Management S.A. lifted its stake in Danaher by 8.1% in the first quarter. Assenagon Asset Management S.A. now owns 38,919 shares of the conglomerate’s stock valued at $7,379,000 after buying an additional 2,926 shares during the period. Burns J W & Co. Inc. NY lifted its stake in Danaher by 1.9% in the first quarter. Burns J W & Co. Inc. NY now owns 40,051 shares of the conglomerate’s stock valued at $7,594,000 after buying an additional 734 shares during the period. EdgeRock Capital LLC boosted its holdings in Danaher by 8.9% during the first quarter. EdgeRock Capital LLC now owns 2,675 shares of the conglomerate’s stock worth $508,000 after buying an additional 218 shares during the last quarter. Finally, Cidel Asset Management Inc. boosted its holdings in Danaher by 23.0% during the first quarter. Cidel Asset Management Inc. now owns 2,946 shares of the conglomerate’s stock worth $559,000 after buying an additional 550 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Up 5.5%

NYSE DHR opened at $188.78 on Thursday. The firm has a market cap of $133.61 billion, a P/E ratio of 36.51, a P/E/G ratio of 2.28 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock’s 50-day moving average is $178.97 and its 200-day moving average is $201.96. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the firm earned $1.88 EPS. Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. Sell-side analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s payout ratio is presently 30.95%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on DHR. Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Barclays decreased their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. DZ Bank assumed coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Finally, JPMorgan Chase & Co. cut their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.